Oric Pharmaceuticals
ORIC
ORIC
163 hedge funds and large institutions have $979M invested in Oric Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 69 increasing their positions, 33 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
8% more funds holding
Funds holding: 151 → 163 (+12)
23% less capital invested
Capital invested by funds: $1.28B → $979M (-$298M)
40% less funds holding in top 10
Funds holding in top 10: 10 → 6 (-4)
Holders
163
Holding in Top 10
6
Calls
$383K
Puts
$135K
Top Buyers
| 1 | +$27.6M | |
| 2 | +$21.3M | |
| 3 | +$14.2M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$13.9M |
| 5 |
Goldman Sachs
New York
|
+$11.9M |
Top Sellers
| 1 | -$11.6M | |
| 2 | -$10.6M | |
| 3 | -$9.58M | |
| 4 |
JP Morgan Chase
New York
|
-$9.37M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$6.55M |
